Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ACCENDRA HEALTH INC/VA/OMI · Entity 6858 | Director | April 29, 2021 | May 03, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ACCENDRA HEALTH INC/VA/
Report date April 29, 2021 · Filed May 03, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,707 |
Reported balance
After 2021-04-29 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-04-29 · Grant · Acquired 4,098 · Balance 28,707 F1: Restricted stock with one year vesting date. |
| Common StockSEC Table I · non-derivative | IndirectBy the Riordan Family Trust | 20,000 |
Reported balance
Holding disclosure · report date 2021-04-29 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 20,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock with one year vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 29, 2021 Filed May 3, 2021 20:50 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 4,098 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-21-000086 · edgar.xml · nonDerivative · entry 1 Riordan Michael C · CIK 0001795823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,707 F1 · security: Restricted stock with one year vesting date. Read SEC document |
| August 10, 2020 Filed Aug 11, 2020 20:38 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | PurchaseCommon Stock | 20,000 | $13.67 | $273,450.00 |
DisclosureSEC source: 0000075252-20-000111 · edgar.xml · nonDerivative · entry 1 Riordan Michael C · CIK 0001795823 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By the Riordan Family Trust Disclosed balance after: 20,000 F1 · price: Weighted average of the purchase price range of $13.61 through $13.74. Read SEC document |
| May 11, 2020 Filed May 13, 2020 01:41 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 17,242 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-20-000058 · edgar.xml · nonDerivative · entry 1 Riordan Michael C · CIK 0001795823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,609 F1 · security: Restricted stock with one year vesting date. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 13:49 UTC | ACCENDRA HEALTH INC/VA/ OMI · Entity 6858 | GrantCommon Stock | 7,367 | $0.00 | $0.00 |
DisclosureSEC source: 0000075252-19-000143 · edgar.xml · nonDerivative · entry 1 Riordan Michael C · CIK 0001795823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,367 F1 · security: Restricted stock with one year vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.